Diagnostics Inc reports results for the quarter ended in December - Earnings Summary

Co-Diagnostics

16/03/2023 21:02

* Co-Diagnostics Inc  CODX.OQ  reported a quarterly adjusted
loss
of 68 cents​​ per share for the quarter ended in December. The
mean expectation of three analysts for the quarter was for a
loss of 15 cents per share.
    * Revenue fell 93.1% to $1.40 million from a year ago;
analysts
expected $5.50 million. 
    * Co-Diagnostics Inc's reported EPS for the quarter was a
loss
of 68 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Co-Diagnostics Inc shares had risen by 15.5% this quarter.
    * The company reported a quarterly loss of $21.91 million.
    * Wall Street's median 12-month price target for
Co-Diagnostics
Inc is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 16 at 09:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.15          -0.68          Missed
 Sep. 30 2022      -0.04          -0.04          Met
 Jun. 30 2022      0.10           -0.08          Missed
 Mar. 31 2022      0.17           0.34           Beat